Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019Daniela K van Santen, Margaret Hellard, Marc van der Valk et al.|EClinicalMedicine|2022Cited by 38
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studiesRachel Sacks‐Davis, Coralie Khan, Daniela K van Santen et al.|The Lancet HIV|2024Cited by 24
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)Daniela K van Santen, Ashleigh C. Stewart, Joseph Doyle et al.|International Journal of Epidemiology|2023Cited by 4